Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 USD | -5.42% | +0.38% | +12.93% |
09/05 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.93% | 34Cr | |
+8.63% | 12TCr | |
+13.17% | 11TCr | |
-12.76% | 2.23TCr | |
-3.99% | 2.16TCr | |
-7.19% | 1.82TCr | |
-39.93% | 1.76TCr | |
+6.67% | 1.43TCr | |
+33.90% | 1.24TCr | |
-28.60% | 828.11Cr |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Truist Securities Downgrades Mersana Therapeutics to Hold From Buy